Listed at the NASDAQ Exchange (Stock Symbol: ALXN)
How to Open a Trading Account to Invest in How to Buy Alexion Pharmaceuticals Shares
Opening an investment account with an Online Broker is a process that is completed online and requires:
First, choose the broker that best fits you. Here, we present eToro as the primary choice.
Upload an ID and a proof of address (electricity, water bills, etc.) through the Broker's App or via email.
Whether you open it with eToro or with another broker, make sure to choose the correct base currency of the account. With some brokers, changing it once you open the account can be painful. Trading Accounts are available on US Dollars (USD), Euros (EUR), Pound Sterling (GBP), Swiss Franc (CHF), Australian Dollar (AUD) as the base currency. Practically all of them offer the option in US Dollars or Euros.
Once the Broker has approved the account, it's time to deposit cash. The depositing and withdrawing money methods are usually Credit Cards, Bank Transfers or eWallets (PayPal, PaySafe, Skrill, SafetyPay, Neteller, among others). The available options to deposit funds will depend on each Broker. A vital fact to mention is that all of the Brokers presented above allow you to use a simulator on their platform; that is, they allow testing their Demo account, which is Free. In other words, you can open a Demo account, try the platform, and then decide whether to deposit money or not.
Upon the capital is credited into your credited account, you may now buy the Stock.
Is it easy to invest in Alexion Pharmaceuticals Shares?
Online Brokers allow investing in Shares straightforwardly through optimised apps that grant easy and fast access to financial markets. Most platforms resemble a social network or any other phone app: They are designed so that the investor can learn and start trading very quickly, without the need for much prior knowledge. To buy shares of Alexion, you have to:
open a trading account as explained before,
deposit money,
Search for "Alexion" on the Broker's Trading platform, and
press the "Buy" button.
And, done, you are officially investing in the co's shares.
How to buy Alexion Pharmaceuticals Shares
About Alexion Pharmaceuticals
A Boston pharmaceutical company, Alexion Pharmaceuticals Inc., focuses primarily on immune system research and rare blood disorders. Alexion develops the drug Soliris, a treatment for paroxysmal nocturnal haemoglobinuria. The treatment received FDA approval in 2007.
Alexion went public in 1996, just four years after its founding. Traded as ALXN on the Nasdaq, the company is also part of the Nasdaq-100 and the S&P 500 indices. Alexion was added to the Nasdaq-100 in 2011 after the company was valued at $8.5 billion. It replaced the biotechnology company Genzyme Corporation.
Like many other pharmaceutical companies, Alexion is part of an ethical debate surrounding the cost of its medicine. While Soliris is widely available in many countries, its staggering price places it out of reach for most patients. The drug purchasing price is over $400,000, making it one of the most expensive medicines in the world. Alexion has reportedly attempted to convince patients to apply pressure on their governments to pay for Soliris themselves. The contention is compounded because much of the research for Soliris was conducted in publicly funded universities.
